Private-public drive to cut delays in drug development

被引：0
|
作者：
Mundell, Ian
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2008年 / 44卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] On challenges to the private-public dichotomy
    Johansen, Venke Frederike
    Andrews, Therese Marie
    [J]. SOCIAL THEORY & HEALTH, 2017, 15 (01) : 66 - 83
  • [2] Openness in private-public collaboration
    McClellan, RO
    [J]. SCIENCE, 1999, 284 (5417) : 1124 - 1124
  • [3] Private-Public Opinion Discrepancy
    Manfredi, Ren
    Guazzini, Andrea
    Roos, Carla Anne
    Postmes, Tom
    Koudenburg, Namkje
    [J]. PLOS ONE, 2020, 15 (11):
  • [4] Reconsidering the private-public distinction
    Mahajan, Gurpreet
    [J]. CRITICAL REVIEW OF INTERNATIONAL SOCIAL AND POLITICAL PHILOSOPHY, 2009, 12 (02) : 133 - 143
  • [5] The need for private-public partnerships
    不详
    [J]. NATURE MEDICINE, 2000, 6 (05) : 481 - 481
  • [6] Evaluating the effects of Quebec's private-public drug insurance system
    Morgan, Steven G.
    Gagnon, Marc-Andre
    Charbonneau, Mathieu
    Vadeboncoeur, Alain
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (40) : E1259 - E1263
  • [7] Measuring the urban private-public interface
    van Nes, A.
    [J]. SUSTAINABLE CITY V: URBAN REGENERATION AND SUSTAINABILITY, 2009, 117 : 389 - 398
  • [8] Identification of the private-public wage gap
    Rattso, Jorn
    Stokke, Hildegunn E.
    [J]. LABOUR ECONOMICS, 2019, 59 : 153 - 163
  • [9] The rise of private-public collaboration in nanotechnology
    Zingg, Raphael
    Fischer, Marius
    [J]. NANO TODAY, 2019, 25 : 7 - 9
  • [10] Intermediate care: private-public partnership
    Garner, VA
    [J]. HOSPITAL MEDICINE, 2001, 62 (03): : 132 - 133
12345